defactinib
Showing 1 - 13 of 13
Glioblastoma, Recurrent Glioblastoma Trial in Atlanta (Avutometinib, Biospecimen Collection, Defactinib)
Not yet recruiting
- Glioblastoma
- Recurrent Glioblastoma
- Avutometinib
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Mar 22, 2023
Mesonephric Gynecologic Cancer Trial in United States (VS-6766, Defactinib)
Recruiting
- Mesonephric Gynecologic Cancer
- VS-6766
- Defactinib
-
Basking Ridge, New Jersey
- +6 more
Mar 15, 2023
MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,
Recruiting
- Myelodysplastic Syndromes
- +2 more
- Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
- Defactinib
-
Sydney, New South Wales, Australia
- +3 more
Jan 12, 2023
Pancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma Trial in Saint Louis (device, drug, procedure)
Recruiting
- Pancreas Cancer
- +2 more
- MR-guided stereotactic body radiation therapy
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 29, 2023
Advanced Solid Tumors, Solid Tumors, Pancreatic Cancer Trial in Rochester, Saint Louis (Defactinib, Pembrolizumab, Gemcitabine)
Completed
- Advanced Solid Tumors
- +2 more
- Defactinib
- +2 more
-
Rochester, Minnesota
- +1 more
Jul 18, 2021
NSCLC, Low Grade Serous Ovarian Cancer, Endometrioid Carcinoma Trial in United Kingdom (VS-6766, Defactinib)
Recruiting
- NSCLC
- +3 more
- VS-6766
- Defactinib
-
Manchester, Greater Manchester, United Kingdom
- +4 more
Mar 18, 2022
Malignant Pleural Mesothelioma Trial in Boston (Pembrolizumab, Defactinib)
Withdrawn
- Malignant Pleural Mesothelioma
- Pembrolizumab
- Defactinib
-
Boston, Massachusetts
- +1 more
Nov 16, 2020
Carcinoma, Non-small-cell Lung, Mesothelioma, Pancreatic Tumors Trial in United Kingdom (Defactinib, Pembrolizumab)
Unknown status
- Carcinoma, Non-small-cell Lung
- +2 more
- Defactinib
- Pembrolizumab
-
Belfast, United Kingdom
- +4 more
Mar 16, 2018
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Healthy Subjects Trial (defactinib)
Completed
- Healthy Subjects
- defactinib
- (no location specified)
Jan 26, 2017
Non Hematologic Cancers Trial in Osaka (Defactinib)
Completed
- Non Hematologic Cancers
- Defactinib
-
Osaka, JapanKinki University Hospital
Jan 26, 2017